Detalles de la búsqueda
1.
Tumor growth inhibition and immune system activation following treatment with thorium-227 conjugates and PD-1 check-point inhibition in the MC-38 murine model.
Front Med (Lausanne)
; 9: 1033303, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36457578
2.
Advances in Precision Oncology: Targeted Thorium-227 Conjugates As a New Modality in Targeted Alpha Therapy.
Cancer Biother Radiopharm
; 35(7): 497-510, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32255671
3.
Synergistic Effect of a HER2 Targeted Thorium-227 Conjugate in Combination with Olaparib in a BRCA2 Deficient Xenograft Model.
Pharmaceuticals (Basel)
; 12(4)2019 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31618864
4.
Synergistic Effect of a Mesothelin-Targeted 227Th Conjugate in Combination with DNA Damage Response Inhibitors in Ovarian Cancer Xenograft Models.
J Nucl Med
; 60(9): 1293-1300, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30850485
5.
Preclinical Combination Studies of an FGFR2 Targeted Thorium-227 Conjugate and the ATR Inhibitor BAY 1895344.
Int J Radiat Oncol Biol Phys
; 105(2): 410-422, 2019 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31255687
6.
Mesothelin-Targeted Thorium-227 Conjugate (MSLN-TTC): Preclinical Evaluation of a New Targeted Alpha Therapy for Mesothelin-Positive Cancers.
Clin Cancer Res
; 25(15): 4723-4734, 2019 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31064781
7.
In Vitro and In Vivo Efficacy of a Novel CD33-Targeted Thorium-227 Conjugate for the Treatment of Acute Myeloid Leukemia.
Mol Cancer Ther
; 15(10): 2422-2431, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27535972
Resultados
1 -
7
de 7
1
Próxima >
>>